1. "2024"
Formats
  1. Journal Article (2329)
  2. Meeting Abstract (1694)
  3. Review (589)
  4. Editorial (305)
  5. Book Section (98)
  6. Correspondence (92)
  7. Guidelines (90)
  8. Research Letter (89)
  9. Miscellaneous (55)
  10. Conference Paper (33)
  11. Book Whole (3)
Groups
  1. Department of Medicine (2141)
  2. Solid Tumor Oncology Division (1382)
  3. Sloan Kettering Institute Postdocs (1038)
  4. Surgery (984)
  5. Graduate Medical Education (883)
  6. GSK Faculty (868)

More Groups

People
  1. Eileen O'Reilly (75)
  2. Saad Usmani (75)
  3. Edward Christopher Dee (70)
  4. Nadeem Abu-Rustum (70)
  5. Alice Wei (69)
  6. T Peter Kingham (68)

More People

Years
  1. 2024 (5377)
Publications
  1. Journal of Clinical Oncology (521)
  2. International Journal of Radiation Oncology, Biology, Physics (186)
  3. Blood (161)
  4. Annals of Oncology (147)
  5. Annals of Surgical Oncology (131)
  6. Laboratory Investigation (91)

More Publications

Publishers
  1. Elsevier Inc. (784)
  2. American Society of Clinical Oncology (580)
  3. Nature Publishing Group (384)
  4. Springer (357)
  5. Oxford University Press (347)
  6. Elsevier Science, Inc. (256)

More Publishers

Results (5377)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Updated efficacy and safety of larotrectinib (laro) in patients (pts) with TRK fusion gastrointestinal (GI) cancer
    Meeting Abstract

    Shen, L.; Andre, T.; Chung, H. C. C.; Deeken, J. F.; Garralda, E.; Italiano, A.; Leyvraz, S.; Liu, T.; Burcoveanu, D. I.; Grugel, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • An online rectal cancer tumoroid biorepository: A resource to facilitate multimodal data integration
    Meeting Abstract

    Alvarez, J.; Zambare, W.; Wu, C.; Bleu, P.; Bercz, A.; Satravada, B.; Kundra, R.; De Bruijn, I.; Schultz, N.; Shia, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of LY3537982, a potent and highly selective KRAS G12C inhibitor in KRAS G12C-mutant GI cancers: Results from a phase 1 study
    Meeting Abstract

    Hollebecque, A.; Kuboki, Y.; Murciano-Goroff, Y. R.; Yaeger, R.; Cassier, P. A.; Heist, R. S.; Fujiwara, Y.; Deming, D. A.; Ammakkanavar, N.; Patnaik, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Intrahepatic cholangiocarcinoma: Recurrence patterns, genomics and survival
    Meeting Abstract

    Chandra, P.; Song, Y.; Drill, E. N.; Wei, A. C. C.; Kemeny, N. E.; Cercek, A.; Connell, L. C.; Harding, J. J.; Abou-Alfa, G. K.; Park, W.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Diagnostic performance of endoscopy and MRI in identifying true response among patients with rectal cancer treated with total neoadjuvant therapy and selective watch and wait or TME
    Meeting Abstract

    Omer, D. M. R.; Williams, H.; Lin, S. T.; Thompson, H. M.; Verheij, F. S.; Yuval, J. B.; Buckley, J. T.; Qin, L. X.; Gollub, M. J.; Garcia-Aguilar, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with metastatic colitis-associated cancer treated with EGFR inhibitors
    Meeting Abstract

    Yeh, C.; Cowley, C.; Srivastava, A.; Chatila, W. K.; Ismailgeci, D.; Chou, J. F.; Capanu, M.; Shah, M. A.; Sanchez-Vega, F.; Ganesh, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Local excision to enhance organ preservation in rectal cancer after favorable response to total neoadjuvant therapy
    Meeting Abstract

    Bercz, A.; Rosen, R.; Drescher, M.; Gonen, M.; Shia, J.; Nishimura, M.; Romesser, P. B.; Crane, C. H.; Saltz, L. B.; Cercek, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Enhancing patient selection for salvage radical prostatectomy: A new riskstratification model from a large retrospective cohort
    Meeting Abstract

    Calleris, G.; Marra, G.; Benfant, N.; Rajwa, P.; Ahmed, M.; Ghoreifi, A.; Abreu, A.; Ribeiro, L.; Westhofen, T.; Tourinho-Barbosa, R.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Phase 3 study of disitamab vedotin with pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2 (DV-001; trial in progress)
    Meeting Abstract

    Powles, T.; Grande, E.; Van Der Heijden, M.; Necchi, A.; Iyer, G.; Drakaki, A.; Loriot, Y.; Sokolowski, K.; Zhang, W.; Galsky, M.
    European Urology (2024)

    Fulltext@MSK | Save
  • Analysis of the Tumor MicroEnvironment (TME) in high-grade Ta (HG Ta) bladder cancer reveals an immune and stromal enriched subtype which demonstrates poor prognosis with concurrent carcinoma-in situ (CIS)
    Meeting Abstract

    Mark, F.; Jacob, T.; Pietzak, E.
    European Urology (2024)

    Fulltext@MSK | Save